How much is the latest market price of acotinib/acalabrutinib?

Acalabrutinib (Acalabrutinib) is a targeted drug used to treat certain types of hematological malignancies, especially in the treatment of mantle cell lymphoma, chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). As a selective Bruton's tyrosine kinase (BTK) inhibitor, acotinib can effectively block the proliferation signals of tumor cells, thereby inhibiting the growth and spread of cancer cells. The drug has shown good efficacy and tolerability in clinical trials and has promising applications, especially in patients who are resistant to other treatment options.

In China, acotinib was approved for marketing in 2023 and was quickly included in medical insurance, allowing more patients to receive this advanced treatment. However, due to its high market price, each box (100mg*8 capsules) costs about more than 40,000 yuan, which has brought a financial burden to many families. Although the coverage of medical insurance has alleviated the cost pressure of patients to a certain extent, it is still a considerable expense for low- and middle-income groups.

In recent years, with the continuous development of the global drug market, generic drugs of acotinib have gradually entered the market. For example, the generic drug of acotinib produced by Laos Pharmaceutical Company is sold in the specification of 100mg*60 tablets and the price is about more than 3,000 yuan, which has obvious price advantages. This provides more options for patients who require long-term treatment, helping them reduce medical costs while ensuring the continuity and effectiveness of treatment.

In the future, as technology advances and market competition intensifies, it is foreseeable that the price of acotinib may further decline. At the same time, the application field of acotinib may also be expanded to other types of tumor treatment, and researchers are actively exploring its efficacy and safety in different diseases.

Reference materials:https://www.calquence.com/